Independent Advisor Alliance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.01M | Sell |
10,187
-89
| -0.9% | -$48.3K | 0.05% | 314 |
|
|
2025
Q4 | $5.95M | Buy |
10,276
+1,354
| +15% | +$766K | 0.14% | 115 |
|
|
2025
Q3 | $4.33M | Buy |
8,922
+200
| +2% | +$93.1K | 0.11% | 158 |
|
|
2025
Q2 | $3.54M | Sell |
8,722
-1,321
| -13% | -$552K | 0.1% | 175 |
|
|
2025
Q1 | $5M | Buy |
10,043
+107
| +1% | +$58K | 0.17% | 104 |
|
|
2024
Q4 | $5.17M | Sell |
9,936
-2,587
| -21% | -$1.42M | 0.07% | 262 |
|
|
2024
Q3 | $7.75M | Buy |
12,523
+246
| +2% | +$146K | 0.28% | 67 |
|
|
2024
Q2 | $6.79M | Buy |
12,277
+1,618
| +15% | +$927K | 0.23% | 77 |
|
|
2024
Q1 | $6.2M | Sell |
10,659
-2,501
| -19% | -$1.4M | 0.22% | 84 |
|
|
2023
Q4 | $6.91M | Buy |
13,160
+2,691
| +26% | +$1.3M | 0.25% | 75 |
|
|
2023
Q3 | $5.3M | Buy |
10,469
+476
| +5% | +$254K | 0.24% | 78 |
|
|
2023
Q2 | $5.21M | Buy |
9,993
+3,183
| +47% | +$1.72M | 0.23% | 83 |
|
|
2023
Q1 | $3.92M | Buy |
6,810
+1,666
| +32% | +$939K | 0.19% | 103 |
|
|
2022
Q4 | $447K | Buy |
5,144
+296
| +6% | +$157K | 0.15% | 83 |
|
|
2022
Q3 | $2.46M | Buy |
4,848
+189
| +4% | +$106K | 0.14% | 138 |
|
|
2022
Q2 | $2.53M | Sell |
4,659
-2,266
| -33% | -$1.25M | 0.14% | 133 |
|
|
2022
Q1 | $4.09M | Buy |
6,925
+2,538
| +58% | +$1.46M | 0.2% | 102 |
|
|
2021
Q4 | $2.93M | Buy |
4,387
+148
| +3% | +$92.4K | 0.14% | 122 |
|
|
2021
Q3 | $2.42M | Buy |
4,239
+147
| +4% | +$80.7K | 0.13% | 137 |
|
|
2021
Q2 | $2.06M | Buy |
4,092
+73
| +2% | +$34.4K | 0.11% | 168 |
|
|
2021
Q1 | $1.83M | Sell |
4,019
-1,949
| -33% | -$930K | 0.11% | 163 |
|
|
2020
Q4 | $2.78M | Buy |
5,968
+99
| +2% | +$46.4K | 0.19% | 112 |
|
|
2020
Q3 | $2.61M | Buy |
5,869
+468
| +9% | +$193K | 0.2% | 108 |
|
|
2020
Q2 | $1.96M | Sell |
5,401
-52
| -1% | -$17.4K | 0.21% | 96 |
|
|
2020
Q1 | $1.55M | Sell |
5,453
-772
| -12% | -$243K | 0.22% | 87 |
|
|
2019
Q4 | $2.02M | Buy |
6,225
+502
| +9% | +$152K | 0.09% | 236 |
|
|
2019
Q3 | $1.67M | Buy |
5,723
+2,005
| +54% | +$574K | 0.2% | 104 |
|
|
2019
Q2 | $1.09M | Buy |
3,718
+27
| +0.7% | +$7.44K | 0.16% | 131 |
|
|
2019
Q1 | $1.01M | Buy |
3,691
+141
| +4% | +$35.1K | 0.14% | 140 |
|
|
2018
Q4 | $794K | Buy |
3,550
+21
| +0.6% | +$4.93K | 0.14% | 146 |
|
|
2018
Q3 | $804K | Buy |
3,529
+582
| +20% | +$134K | 0.14% | 155 |
|
|
2018
Q2 | $553K | Buy |
2,947
+89
| +3% | +$18.9K | 0.12% | 175 |
|
|
2018
Q1 | $581K | Buy |
2,858
+530
| +23% | +$111K | 0.13% | 172 |
|
|
2017
Q4 | $472K | Buy |
2,328
+234
| +11% | +$44.8K | 0.11% | 186 |
|
|
2017
Q3 | $405K | Buy |
+2,094
| New | +$379K | 0.11% | 166 |
|
Other funds holding TMO
VCM
Independent Advisor Alliance's TMO Position: Q1 2026 in Review
Independent Advisor Alliance reduced its Thermo Fisher Scientific (TMO) stake by 0.87% in Q1 2026, selling an estimated $48.3K and leaving 10,187 shares worth $5.01M. The position accounts for 0.05% of the portfolio, ranked #314.
Independent Advisor Alliance first reported a position in TMO in Q3 2017 and has held it in 35 quarters since. The position peaked at $7.75M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Independent Advisor Alliance held 10,187 shares of Thermo Fisher Scientific worth $5.01M as of Q1 2026.
- Independent Advisor Alliance sold 89 Thermo Fisher Scientific shares in Q1 2026, an estimated $48.3K.
- Thermo Fisher Scientific made up 0.05% of Independent Advisor Alliance's portfolio in Q1 2026, its #314 holding.
- Independent Advisor Alliance first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 35 quarters since.
- Independent Advisor Alliance's Thermo Fisher Scientific position peaked at $7.75M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.